Unknown

Dataset Information

0

Synthesis and Anticancer Activity of Hybrid Molecules Based on Lithocholic and (5Z,9Z)-Tetradeca-5,9-dienedioic Acids Linked via Mono(di,tri,tetra)ethylene Glycol and ?,?-Diaminoalkane Units.


ABSTRACT: For the first time, hybrid molecules were synthesized on the basis of lithocholic and (5Z,9Z)-1,14-tetradeca-5,9-dienedicarboxylic acids, obtained in two stages using the homo-cyclomagnesiation reaction of 2-(hepta-5,6-diene-1-yloxy)tetrahydro-2H-pyran at the key stage. The resulting hybrid molecules containing 5Z,9Z-dienoic acids are of interest as novel synthetic biologically active precursors to create modern drugs for the treatment of human oncological diseases. The synthesized hybrid molecules were found to exhibit extremely high in vitro inhibitory activity against human topoisomerase I, which is 2-4 times higher than that of camptothecin, a known topoisomerase I inhibitor. Using flow cytometry and fluorescence microscopy, it was first shown that these new molecules are efficient apoptosis inducers in HeLa, U937, Jurkat, K562, and Hek293 cell cultures. In addition, the results of investigations into the effect of the synthesized acids on mitochondria and studies of possible DNA damage in Jurkat tumor cells are also presented.

SUBMITTER: D'yakonov VA 

PROVIDER: S-EPMC7911507 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis and Anticancer Activity of Hybrid Molecules Based on Lithocholic and (5<i>Z</i>,9<i>Z</i>)-Tetradeca-5,9-dienedioic Acids Linked via Mono(di,tri,tetra)ethylene Glycol and α,ω-Diaminoalkane Units.

D'yakonov Vladimir A VA   Tuktarova Regina A RA   Dzhemileva Lilya U LU   Ishmukhametova Svetlana R SR   Dzhemilev Usein M UM  

Pharmaceuticals (Basel, Switzerland) 20210123 2


For the first time, hybrid molecules were synthesized on the basis of lithocholic and (5<i>Z</i>,9<i>Z</i>)-1,14-tetradeca-5,9-dienedicarboxylic acids, obtained in two stages using the homo-cyclomagnesiation reaction of 2-(hepta-5,6-diene-1-yloxy)tetrahydro-2H-pyran at the key stage. The resulting hybrid molecules containing 5<i>Z</i>,9<i>Z</i>-dienoic acids are of interest as novel synthetic biologically active precursors to create modern drugs for the treatment of human oncological diseases. T  ...[more]

Similar Datasets

| S-EPMC3884309 | biostudies-literature
| S-EPMC5629410 | biostudies-literature
| S-EPMC3815657 | biostudies-literature
| S-EPMC4021451 | biostudies-literature
| S-EPMC6007355 | biostudies-other
2017-07-14 | PXD004919 | Pride
| S-EPMC10711453 | biostudies-literature
| S-EPMC6249031 | biostudies-literature
| S-EPMC3502918 | biostudies-literature
| S-EPMC10815636 | biostudies-literature